Has the Time for At-Home Cancer Care Finally Come?
A Penn Medicine team debuts its program focused on cancer care at home — just in time for COVID-19.
Endocrine Cancer
ENDOCRINE CANCER ADVISOR
FEATURED CONTENT
-
-
A New Look at the Dose-Response Relationship in Phase 1 Oncology Trials
The new generation of cancer drugs behave quite differently than cytotoxic therapies, and that may mean phase 1 trials need to be updated. -
Researchers Turn to Crowdsourcing to Learn More About COVID-19 and Cancer
Pooling data from physicians and patients appears to be an efficient way to answer urgent questions. -
Not Developing Any New Drugs Could Be EQRx’s Biggest Innovation
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing. -
“Medical Distancing” May Help Protect Cancer Patients From Exposure to COVID-19
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.
ENDOCRINE CANCER NEWS
FDA: Unacceptable NDMA Levels Identified in Certain Metformin ER Products
Retevmo Gets Accelerated Approval for RET-Driven Lung, Thyroid Cancers
Regular Medical Surveillance in World Trade Center Emergency Personnel May Explain Increased Rates of Thyroid Cancer
Aggressive Subtypes of Papillary Thyroid Cancer Deserve Increased Attention
Therapeutic Advancements Have Facilitated Surgery Optimization, ASCO Officials Report
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Endocrine Cancer
